SCA
FLXN

SAC Capital Advisors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

SAC Capital Advisors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,769
Closed -$391K – 1185
2014
Q1 		$391K Buy
+23,769
New +$411K ﹤0.01% 1296

Other funds holding FLXN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAC Capital Advisors's FLXN Position: Q2 2014 in Review

SAC Capital Advisors sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2014, closing a stake of 23,769 shares — an estimated $391K sold.

SAC Capital Advisors first reported a position in FLXN in Q1 2014 and held it in 1 quarter. The position peaked at $391K in Q1 2014. 42 funds tracked by Wall St. Rank hold FLXN as of Q2 2014.

  • SAC Capital Advisors reported no remaining Flexion Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 23,769 Flexion Therapeutics, Inc. shares in Q2 2014, an estimated $391K.
  • SAC Capital Advisors first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 1 quarter.
  • SAC Capital Advisors's Flexion Therapeutics, Inc. position peaked at $391K in Q1 2014.
  • 42 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.